Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults

NCT04502693 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3657

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Meningococcal

Interventions

COMBINATION_PRODUCT: rMenB+OMV NZ vaccine
BIOLOGICAL: Meningococcal Groups A, C, W and Y Conjugate Vaccine (MenACWY)
COMBINATION_PRODUCT: Placebo
COMBINATION_PRODUCT: MenABCWY-1
COMBINATION_PRODUCT: MenABCWY-2
COMBINATION_PRODUCT: MenABCWY-3

Sponsor

GlaxoSmithKline